Observational Study on Half-Dose Magnesium Sulphate Therapy in Treatment of Preeclampsia and Eclampsia in Assam Medical College
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.144 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Susila Devi P und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To evaluate the efficacy and safety of half-dose magnesium sulphate therapy in the management of preeclampsia and eclampsia among mothers with BMI less than 30 kg/m2 at Assam Medical College and Hospital, Dibrugarh.
Methods
This hospital-based prospective observational study included 80 pregnant women diagnosed with preeclampsia or eclampsia and having BMI
Zitieren
APA
P, S. D., Majumdar, M. K., Kurmi, B., Saikia, N., & Saikia, D. (2026). Observational Study on Half-Dose Magnesium Sulphate Therapy in Treatment of Preeclampsia and Eclampsia in Assam Medical College. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.144
Vancouver
P SD, Majumdar MK, Kurmi B, Saikia N, Saikia D. Observational Study on Half-Dose Magnesium Sulphate Therapy in Treatment of Preeclampsia and Eclampsia in Assam Medical College. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.144
BibTeX
@article{P2026,
author = {P, Susila Devi and Majumdar, Manoj Kumar and Kurmi, Bandana and Saikia, Nabajyoti and Saikia, Dayananda},
title = {Observational Study on Half-Dose Magnesium Sulphate Therapy in Treatment of Preeclampsia and Eclampsia in Assam Medical College},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.144}
}
EUVIMED